Lesley Mitchell

2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014

Management of Stroke in Infants and Children

Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke

Best Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on Asparaginase

Long-Term Anticoagulation in Kawasaki Disease: Initial Use of Low Molecular Weight Heparin is a Viable Option for Patients with Severe Coronary Artery Abnormalities

Pharmacology and Management of the Vitamin K Antagonists

Mechanisms of Thrombus Formation

Heparin Therapy in Pediatric Patients: A Prospective Cohort Study

Long-term anticoagulation therapy and thromboembolic complications after the Fontan procedure

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

Heparin Cofactor II

Prognosis of Cancers Associated with Venous Thromboembolism

Laboratory Testing for Heparin-Induced Thrombocytopenia

Mapping of nucleic acid binding in proteolytic domains of HIV-1 reverse transcriptase

Management of occlusion and thrombosis associated with long-term indwelling central venous catheters

Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy

Oral Anticoagulant Therapy

Nanoparticle therapeutics: an emerging treatment modality for cancer

Emergency Hospitalizations for Adverse Drug Events in Older Americans

Prethrombotic Disorders in Children With Arterial Ischemic Stroke and Sinovenous Thrombosis

Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis

Temporal Aspects of Heparin-Induced Thrombocytopenia

Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction

Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease

Pegaspargase: a review of clinical studies

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

Antithrombotic Therapy for VTE Disease

Polymer conjugates as anticancer nanomedicines

Acute kidney injury

Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial

Fibrinolytic response to venous occlusion is decreased in patients after Kawasaki disease

Cerebral Sinovenous Thrombosis in Children

Oral Anticoagulants

Prevention of Venous Thromboembolism

Sickle-cell disease

Hepatorenal Disorders

Prevalence of antithrombin deficiency in the healthy population

Secondary prevention with folic acid: effects on clinical outcomes

Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty

Cancer and venous thromboembolism

Incidence, risk factors, and treatment patterns for deep venous thrombosis in hospitalized children: An increasing population at risk

Prophylaxis of Venous Thromboembolism Using Two Different Doses of Low-Molecular-Weight Heparin (Nadroparin) in Bariatric Surgery: A Prospective Randomized Trial

Antithrombotic Therapy in Neonates and Children

Antithrombotic Therapy in Neonates and Children

Prothrombotic Disorders in Infants and Children With Cerebral Thromboembolism

The Pharmacology and Management of the Vitamin K Antagonists

Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies

Guidelines for the Prevention of Intravascular Catheter-related Infections

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association

Chemotherapy-induced thrombosis

Pharmacotherapeutic Aspects of Unfractionated and Low Molecular Weight Heparins

Engineered Nanoparticles for Drug Delivery in Cancer Therapy

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy

Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management

Guidelines for the Early Management of Patients With Acute Ischemic Stroke

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE

Maturation of the hemostatic system during childhood

Serpin Structure, Mechanism, and Function

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis

Deep vein thrombosis associated with central venous catheters – a review

Transcranial Doppler Screening Among Children and Adolescents With Sickle Cell Anemia

Anticoagulation Monitoring during Cardiac Surgery 

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

Aggregation-Induced Emission: Together We Shine, United We Soar!

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

When should DVT be suspected in children with osteomyelitis?

Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension

Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

American Heart Association/American College of Cardiology Foundation guide to warfarin therapy11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement has been co-published in the April 1, 2003, issue of Circulation.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in October 2002 and by the American College of Cardiology Board of Trustees in February 2003. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0254. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.

Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease

Cancer treatment and survivorship statistics, 2016

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of postthrombotic syndrome in children

Oltipraz, an inhibitor of human immunodeficiency virus type 1 replication.

Promotion of Physical Activity for Children and Adults With Congenital Heart Disease

Venous Thrombosis Associated With Staphylococcal Osteomyelitis in Children

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease

Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism

Randomized Trial of Prevention of Catheter-Related Bloodstream Infection by Continuous Infusion of Low-Dose Unfractionated Heparin in Patients With Hematologic and Oncologic Disease

Multicenter and Retrospective Case Study of Warfarin and Aspirin Combination Therapy in Patients With Giant Coronary Aneurysms Caused by Kawasaki Disease

Pharmacological and clinical evaluation of l-asparaginase in the treatment of leukemia

Venous thrombosis: a multicausal disease

Assembly of an Active Group II Intron−Maturase Complex by Protein Dimerization

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management

Frequency, Predictors, and Neurologic Outcomes of Vaso-occlusive Strokes Associated With Cardiac Surgery in Children

An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus.

The effect  of  1  month  of  therapy with midodrine, octreotide‐LAR and albumin in refractory ascites: a pilot study

Thrombosis in childhood acute lymphoblastic leukaemia: epidemiology, aetiology, diagnosis, prevention and treatment

Acquired antithrombin III deficiency secondary to asparaginase therapy in childhood acute lymphoblastic leukaemia

Antithrombotic therapy in children

Lack of correlation between heparin dose and standard clinical monitoring tests in treatment with unfractionated heparin in critically III children

Decreased Thrombin Activity of Fibrin Clots Prepared in Cord Plasma Compared with Adult Plasma

KIDCLOT©: The importance of validated educational intervention for optimal long term warfarin management in children

A clinically significant incidence of bleeding in critically ill children receiving therapeutic doses of unfractionated heparin: a prospective cohort study

Active site studies of human immunodeficiency virus reverse transcriptase

Significant association with location of central venous line placement and risk of venous thrombosis in children

Systemic thromboembolism in children

Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia

Anticoagulant Effects of Heparin in Neonatal Plasma'

A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L‐asparaginase

A case series of 72 neonates with renal vein thrombosis

A cross-sectional study evaluating post-thrombotic syndrome in children

Population pharmacokinetics of enoxaparin in infants, children and adolescents during secondary thromboembolic prophylaxis: a cohort study

The Relationship of Antiphospholipid Antibodies to Thromboembolic Events in Pediatric Patients with Systemic Lupus Erythematosus: A Cross-Sectional Study

Dose-finding and pharmacokinetics of therapeutic doses of tinzaparin in pediatric patients with thromboembolic events

A Placebo-controlled Randomized Trial of Antithrombin Therapy in Neonatal Respiratory Distress Syndrome

Central venous line–related thrombosis in children: association with central venous line location and insertion technique

Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L'Asparaginase-induced antithrombin III deficiency

Urgent Clinical Challenges in Children With Ischemic Stroke

Alpha-2-Macroglobulin Is an Important Progressive Inhibitor of Thrombin in Neonatal and Infant Plasma

Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children

Thrombin Generation in Newborn Plasma Is Critically Dependent on the Concentration of Prothrombin

Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic Antithrombin Replacement in Kids with ALL treated with Asparaginase.

Conventional Chromogenic Heparin Assays are Influenced by Patient's Endogenous Plasma Antithrombin Levels

Comparison of Venography and Ultrasound for the Diagnosis of Asymptomatic Deep Vein Thrombosis in the Upper Body in Children

Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus

Coagulation and Fibrinolytic Profile of Paediatric Patients Undergoing Cardiopulmonary Bypass

Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient children

A Low Molecular Weight Heparin Alters the Fetal Coagulation System in the Pregnant Sheep

An Antithrombin III Assay Based on Factor Xa Inhibition Provides a More Reliable Test to Identify Congenital Antithrombin III Deficiency Than an Assay Based on Thrombin Inhibition

Thrombin Regulation in Children Differs from Adults in the Absence and Presence of Heparin

Development of the human coagulation system in the healthy premature infant

Analysis of Warfarin Therapy in Pediatric Patients: A Prospective Cohort Study of 319 Patients